Huntington National Bank’s Tarsus Pharmaceuticals TARS Stock Holding History

Huntington National Bank’s Portfolio TARS Stock Details TARS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$217K	Buy	3,446 +3,445	+344,500%	+$220K	﹤0.01%	887
2026 Q1	$70	Hold	1	–	–	﹤0.01%	2713
2025 Q4	$82	Hold	1	–	–	﹤0.01%	2588
2025 Q3	$59	Hold	1	–	–	﹤0.01%	2812
2025 Q2	$41	Hold	1	–	–	﹤0.01%	3053
2025 Q1	$51	Hold	1	–	–	﹤0.01%	2955
2024 Q4	$55	Hold	1	–	–	﹤0.01%	2943
2024 Q3	$33	Hold	1	–	–	﹤0.01%	3213
2024 Q2	$27	Hold	1	–	–	﹤0.01%	3286
2024 Q1	$36	Sell	1 -1,500	-100%	-$44.1K	﹤0.01%	2991
2023 Q4	$30.4K	Hold	1,501	–	–	﹤0.01%	1281
2023 Q3	$26.7K	Hold	1,501	–	–	﹤0.01%	1259
2023 Q2	$27.1K	Hold	1,501	–	–	﹤0.01%	1268
2023 Q1	$18.9K	Buy	+1,501	New	+$22K	﹤0.01%	1336

Other funds holding TARS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Huntington National Bank's TARS Position: Q2 2026 in Review

Huntington National Bank increased its Tarsus Pharmaceuticals (TARS) stake by 344,500% in Q2 2026, buying an estimated $220K and bringing the position to 3,446 shares worth $217K. The position accounts for ﹤0.01% of the portfolio, ranked #887.

Huntington National Bank first reported a position in TARS in Q1 2023 and has held it in 14 quarters since. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

Huntington National Bank held 3,446 shares of Tarsus Pharmaceuticals worth $217K as of Q2 2026.
Huntington National Bank bought 3,445 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $220K.
Tarsus Pharmaceuticals made up ﹤0.01% of Huntington National Bank's portfolio in Q2 2026, its #887 holding.
Huntington National Bank first reported a position in Tarsus Pharmaceuticals in Q1 2023 and has held it in 14 quarters since.
257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.